首页> 外文OA文献 >SuO013ALANYL-GLUTAMINE IN PERITONEAL DIALYSIS FLUIDS IMPROVES PERITONEAL HEALTH AND SYSTEMIC INFLAMMATION: A DOUBLE-BLINDED RANDOMIZED CROSSOVER TRIAL

【2h】

SuO013ALANYL-GLUTAMINE IN PERITONEAL DIALYSIS FLUIDS IMPROVES PERITONEAL HEALTH AND SYSTEMIC INFLAMMATION: A DOUBLE-BLINDED RANDOMIZED CROSSOVER TRIAL

机译：腹膜透析液中的Suo013 alanyl-谷氨酰胺改善了腹膜健康和全身炎症：双盲随机交叉试验

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Andreas Vychytil; Rebecca Herzog; Paul Probst; Werner Ribitsch; Karl Lhotta; Veronika Machold-Fabrizii; Martin Wiesholzer; Michaela Kaufmann; Hermann Salmhofer; Martin Windpessl; Franz König; Alexander Rosenkranz; Rainer Oberbauer; Klaus Kratochwill; Christoph Aufricht;
展开▼
作者单位

展开▼
年度 2018
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Short-term effects of a new bicarbonate/lactate-buffered and conventional peritoneal dialysis fluid on peritoneal and systemic inflammation in CAPD patients: a randomized controlled study. [J] . Pajek J, Kveder R, Bren A, Peritoneal dialysis international: Journal of the International Society for Peritoneal Dialysis . 2008,第1期

机译：新型碳酸氢盐/乳酸盐缓冲液和常规腹膜透析液对CAPD患者腹膜和全身炎症的短期影响：一项随机对照研究。
2. Anti-Inflammatory interventions in end-stage kidney disease: A randomized, double-blinded, controlled and crossover clinical trial on the use of pravastatin in continuous ambulatory peritoneal dialysis [J] . Cueto-ManzanoA.M., ángel-Zú?igaJ.R., Ornelas-CarrilloG., Archives of medical research . 2013,第8期

机译：终末期肾脏疾病的抗炎干预措施：普伐他汀用于连续非卧床腹膜透析的随机，双盲，对照和交叉临床试验
3. Twelve Weeks of Pioglitazone Therapy Significantly Attenuates Dysmetabolism and Reduces Inflammation in Continuous Ambulatory Peritoneal Dialysis Patients—a Randomized Crossover Trial [J] . Chuan-ming Hao, Huai-zhou You, Jing Tian, Peritoneal dialysis international: Journal of the International Society for Peritoneal Dialysis . 2012,第5期

机译：连续12周的吡格列酮疗法可显着减轻持续性非卧床腹膜透析患者的代谢异常并减少炎症-一项随机交叉试验
4. Eosinophilic Inflammation in Peritoneal Fibrosis Patients Undergoing Peritoneal Dialysis [C] . Takehito Kobayashi, Toru Noguchi, Kohei Saito, Nihon To?seki Igakkai., Gakujutsu Shu?kai So?kai . 2018

机译：腹膜纤维化患者嗜酸性炎症患者接受腹膜透析
5. The effects of a nurse -led case management programme on patients undergoing peritoneal dialysis: A randomized controlled trial [D] . Chow, Susan Ka Yee 2006

机译：护士主导的病例管理计划对腹膜透析患者的影响：一项随机对照试验
6. Twelve Weeks of Pioglitazone Therapy Significantly Attenuates Dysmetabolism and Reduces Inflammation in Continuous Ambulatory Peritoneal Dialysis Patients—a Randomized Crossover Trial [O] . Yun Li, Qiong-hong Xie, Huai-zhou You, 2012

机译：连续12周的吡格列酮治疗可显着减轻持续性非卧床腹膜透析患者的代谢不良和炎症减少这是一项随机交叉试验。
7. Effects of neutral pH and low-glucose degradation product-containing peritoneal dialysis fluid on systemic markers of inflammation and endothelial dysfunction: a randomized controlled 1-year follow-up study [O] . S.-H. Park, J.-Y. Do, Y. H. Kim, 2011

机译：中性pH与低葡萄糖降解产物的腹膜透析液对炎症和内皮功能障碍的全身标志物的影响：随机控制的1年后续研究
8. Investigation of the Risks and Hazards with Devices Associated with Peritoneal Dialysis (Including Intermittent Peritoneal Dialysis and Continuous Ambulatory Peritoneal Dialysis) and Sorbent Regenerated Dialysate Delivery Systems [R] . Ward, R. A. 1982

机译：腹膜透析（包括间歇性腹膜透析和持续性非卧床腹膜透析）和吸附剂再生透析液输送系统相关设备的风险和危害调查

SuO013ALANYL-GLUTAMINE IN PERITONEAL DIALYSIS FLUIDS IMPROVES PERITONEAL HEALTH AND SYSTEMIC INFLAMMATION: A DOUBLE-BLINDED RANDOMIZED CROSSOVER TRIAL

著录项

引文网络

相似文献

相关主题

期刊订阅